Condition
Intimal Hyperplasia
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Unknown2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT03994029Not ApplicableUnknown
Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance
NCT03097679Not ApplicableUnknown
Self-expanding Nitinol Stents of High vs. Low Chronic Outward Force in De-novo Femoropopliteal Occlusive Arterial Lesions
NCT00379366Phase 2Terminated
External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access
Showing all 3 trials